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1. Introduction 
Renal cell carcinoma (RCC) accounts for about 3% of all adult malignancies and is the most 
lethal urological cancer. Although extremely rare in pregnant women, it is the commonest 
urological neoplasm in pregnancy occurring in 1 in 1000 cases (Walker, JL., & Knight, EL., 
1986). It is potentially curable with prompt diagnosis and correct management. However, 
treatment of the disease is a substantial challenge for both, urologist and obstetrician.  
Over 70 cases of RCC in pregnancy have been reported in literature. 95% of them are clear 
cell type, with a poorer prognosis than the rest 5% that are chromophobe type. Women with 
these tumors may present at any stage of the pregnancy. Only 26% of them describe the 
classical triad of: loin pain, palpable mass and haematuria. The most common mode of 
presentation of the disease is a palpable mass (88%) and pain (50%).  Haematuria implies 
collecting system invasion and occurs in 50% of the cases. However, haematuria in pregnant 
women is faint due to other possible causes, including: urinary tract infection, calculi and 
hydronephrosis (Pearson, GAH., & Eckford, SD., 2009). Other rare forms of presentations 
are: hypertension, haemolytic anaemia and hypercalcaemia (Monga, et al., 1995; Usta, IM., et 
al., 1998). With the advent of ultrasound there has been a change in presentation of the 
disease with diagnosis more frequently made incidentally during ultrasound examination 
performed for other reasons (Fynn, J., & Venyo, AKG., 2004).  
Diagnostic evaluation of a pregnant woman with renal mass requires special consideration 
combining non-invasive techniques with as little radiation exposure as possible to the 
mother and fetus. As a first step, urine has to be sent for cytology. Abdominal CT and 
intravenous pyelography (IVP) are frequently used in the evaluation of non-pregnant 
patients and should be avoided due to the unsafe radiation exposure to fetus. Renal 
radionuclide scans being used to determine function of a contralateral kidney has to be 
replaced by Doppler scan. Ultrasonography (US) is the safest method for diagnosis of the 
renal mass in pregnant woman with the similar to IVP and CT sensitivity of 85% 
(Warshauer, DM., et al., 1988). Magnetic resonance imaging (MRI) is also suitable, due to the 
least radiation exposure and no harm to pregnant woman. However, it should be stressed 
www.intechopen.com
 
Emerging Research and Treatments in Renal Cell Carcinoma 
 
436 
that chest CT remains the most sensitive method for diagnosis of pulmonary metastases. 
The US and MRI are the investigations of choice adequately identifying, differentiating and 
staging the solid renal masses in pregnancy.  
The management of RCC in pregnant woman should depend on tumor biology and age of 
gestation. Decision to operate and prevent further tumor spread should be taken in 
consideration of the degree of fetal maturity. The impact of surgical and adjuvant therapy 
on the potential for future pregnancies should be also considered. 
The most frequent form of treatment of RCC in pregnancy is open or laparoscopic radical 
nephrectomy (RN) followed-up by spontaneous delivery (Pearson, GA., & Eckford, SD., 
2009; Gnessin, E., et al., 2002; Qureshi, F., et al., 2002; Monga, M., et al., 1995; O'Connor, JP., 
et al., 2004; Lee, D., & Abraham, N., 2008). RN with or without termination of pregnancy 
(Loughlin, KR., 1995; Usta, IM., et al., 1998; Simon, I., et al., 2008), Caesarean section (CS) 
followed-up by RN (Stojnić, J., et al., 2009) and simultaneous RN and CS (Kobayashi, T., et 
al., 2000) have also been reported in the literature. There are no reports on the simultaneous 
nephron sparing surgery (NSS) and CS in the pregnant women. 
Here we report the first case of NSS performed together with CS for the treatment of RCC in 
the second trimester of pregnancy. The review of the literature discussing the tretment 
options, timing of the surgery and multidisciplinarity of approach is also given. 
2. Case history 
A 33 years old female was referred to our center at 24 weeks’ gestation without previous 
history of urological diseases and any subjective complaints. The right renal mass has been 
found on routine sonography. A 6X6X4.5 cm. solid tumor has been detected on MRI arising 
from the upper pole of the right kidney (figure 1). Regional lymph nodes were negative. 
Hepatic and pulmonary metastases have been excluded by abdominal and chest MRI. Renal 
biopsy has not been performed due to the following reasons: a) the positive predictive value 
of the imaging findings is so high that a negative biopsy result would not alter the 
management strategy; b) 10-20% of biopsies are reported to be non-conclusive; c) high risk 
of complications associated with biopsy (Silverman, SG., et al., 2006).  
The tumor was graded according to the Padua anatomical classification and assigned the 
score 6. According to this score the risk of surgical complications related to the NSS was 
considered as low. There were no radiological signs of local extension and/or distant 
metastases. Clinically the tumor was staged as: T1b, N0, M0.  
After extensive counseling and consultation with the obstetrician decision has been taken to 
postpone the operative treatment until the third trimester of gestation as recommended in 
the literature. The patient was followed-up by: regular urological and obstetrical checkup; 
sonography once per month; and weekly urinalysis, until maximal chance of fetal viability. 
The patient was stable without any signs of disease progression until 33rd week of gestation. 
After re-consulting with obstetric staff, simultaneous NSS and caesarian section was 
planned at this time point.  
Caesarian section has been performed first under epidural anesthesia. A healthy girl 
weighing 2.4 kg was delivered without any surgical difficulties. The patient was intubated 
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and operation was continued with open NSS through flank incision. Enucleoresection was 
performed with arterial clamping and local hypothermia. Cold ischemia time was 15 min. 
Duration of the NSS was 115 min. Blood loss was less than 100 cc. The renal capsular defect 
has been covered with free peritoneal graft.  
 
Fig. 1 MRI scan demonstrating right renal mass and the fetus 
Postoperative course was uneventful for both, the mother and child. The patient made a 
good recovery with normal obstetric examinations. Morphology revealed clear cell RCC 
pT1bN0M0, grade 1. After the follow-up of 30 months the patient is doing well without any 
signs of the disease recurrence. The child is healthy with normal physical and mental 
development. 
3. Discussion 
RN and NSS are the treatments of choice for the patients with RCC. Oncological results and 
complications of the treatments are extensively evaluated showing excellent outcomes in the 
patients with local stages of the disease. However, management of RCC in pregnant women 
is extremely challenging due to the rarity and difficulty of the situation. There are several 
reports in the literature about the treatment of RCC at different time points of pregnancy. 
Table 1 describes the cases of the treatment of RCC in pregnancy reported in the literature. 
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It was believed for a long time that there is no association between RCC and pregnancy. 
However, more recent studies discovered new facts. Lambe, M., et al. in a Swedish 
population-based study, found a strong association between the number of births and the 
risk of RCC. They have shown that the parous women were at a 40% increased risk of RCC 
compared to nulliparous women (Lambe, M., et al., 2002). It is known that both, normal and 
malignant renal cells contain oestrogen and progesterone receptors (Ronchi, E., et al., 1984). 
Chow, WH., et al. have shown an increased risk of RCC in pregnant women with co-existing 
risk factors like: parity greater than five, obesity, hypertension and diabetes (Chow, WH., et 
al., 1995). It has been speculated that pregnancy-associated hormonal changes, particularly 
high oestrogen levels, may act as promoters of malignant change by stimulating renal cell 
proliferation either directly or via paracrine growth factors (Concolino, G., et al., 1993). 
Whether these observations have any implications for the biological behavior of malignant 
renal cells in pregnancy is not clear, but a tendency towards immediate rather than delayed 
surgery seems to be appropriate. However, as neonatal survival rates increase with 
increasing gestation at delivery, immediate surgery at early stages of pregnancy is 
potentially deleterious to fetal health. Therefore, it is extremely important to define whether 
pregnancy has to be interrupted or allowed to continue if radical nephrectomy is carried out 
(Fynn, J., & Venyo, AK., 2004).  
If the RCC is discovered in the first trimester, immediate surgery is recommended by 
majority of the authors (Loughlin, KR., 1995; Gladman, MA., et al., 2002). Whether 
pregnancy should be terminated at this gestation or not is debatable. The decision should be 
based on the patient’s wishes and medical indications. It is important to consider that the 
risks of miscarriage and teratogenesis are high at this age, making termination a better 
option for some authors (Fynn, J., & Venyo, AK., 2004). Others however, disagree with this 
approach (Usta, IM., et al., 1998). 
Management of the disease in the second trimester is more challenging. In the late second 
trimester surgery should be delayed to at least 28 weeks, when the fetal survival of over 90% 
is achievable (Loughlin, KR., 1995). In the early second trimester however, immediate 
surgery is recommended by some of the authors due to the low risk of the fetal loss (Fazeli-
Matin, S., et al., 1998; Gnessin, E., et al., 2002; Jenkins, TM., et al., 2003). 
In the third trimester the fetal lung maturity is established and immediate surgery seems 
convenient. It has been suggested that CS should not be performed at the time of RN as the 
kidney is removed through different incision (Walker, JL. & Knight, EL., 1986). If the 
diagnosis is made in the late third trimester the surgery can be postponed until delivery 
(Loughlin, KR., 1995).  
In case of the metastatic disease the pregnancy should be terminated (Hendry, WF., 1997). 
There are no reports of patients or fetal metastases so far. 
The most frequent form of treatment of RCC in pregnancy is open or laparoscopic RN 
followed-up by spontaneous delivery. Gladman, MA., et al. reported 2 cases of RCC 
diagnosed in the second trimester. RN was performed without termination of pregnancy. 
One patient gave birth to healthy child and the second one underwent emergency CS for 
fetal distress at forty weeks’ of gestation (Gladman, MA., et al., 2002). Two cases of 
successful open RN in the second trimester have been reported by Gnessin, E., et al., Both 
patients gave full term spontaneous delivery to healthy children (Gnessin, E., et al., 2002). 
www.intechopen.com
 
Emerging Research and Treatments in Renal Cell Carcinoma 
 
440 
Qureshi, F., et al. detected RCC in the first trimester. Immediate RN was performed through 
a thoraco-abdominal approach. The patient gave birth to a healthy infant at full term by 
spontaneous vaginal delivery (Qureshi, F., et al., 2002). Lee, D. & Abraham, N., and 
O’Connor, J., et al., reported the case of RCC discovered in the first trimester. The operation 
was delayed till the second trimester. Laparoscopic transperitoneal nephrectomy was 
performed at 19 weeks’ gestation in both cases. Both patients delivered a healthy child 
vaginally at 39 weeks’ gestation (Lee, D., & Abraham, N., 2008; O’Connor, J., et al., 2004). 
Simon, I., et al. reported a rare case of Von Hippel-Lindau disease in pregnant women 
presented with haematuria in the first trimester. RN was carried out after pregnancy 
interruption (Simon, I., et al., 2008).  
Pearson, GAH., & Eckford, SD., detected RCC in the third trimester of pregnancy. CS was 
performed at 32 weeks of gestation followed-up by RN two weeks later. The same approach 
has been reported by Stojnić, J., et al. (Stojnić, J., et al., 2009).  
Simultaneous RN and CS has also been performed for the treatment of RCC detected in the 
second trimester (Kobayashi, T., et al, 2000). There are no reports on the simultaneous NSS 
and CS in the literature. 
The data on the effect of pregnancy on long-term survival of RCC is very limited. The same 
is true for the effect of future pregnancies on tumor recurrence. Some authors have reported 
good clinical results and survival in pregnant women with RCC (Walker, JL. & Knight, EL., 
1986). More data on the outcomes of different treatment options, including the effect of 
subsequent pregnancies on the disease recurrence are needed to answer these questions. 
4. Conclusion 
The management of a pregnant woman with a malignant solid renal mass should follow 
certain principles: 1) the welfare of the mother should be main concern, unless she wishes 
otherwise; 2) management of the patient has to take place in a multidisciplinary setting 
involving: urologist, neonatologist, obstetrician, radiologist, anaesthetist, and morphologist;  
3) the standard surgical treatment of the most stages of RCC is RN or NSS; 4) timing of the 
surgery depends on biological behavior of the tumor and the neonatal survival rates for the 
different gestations; 5) In case of widespread metastatic disease, the pregnancy should 
probably be terminated and the woman has to be treated according to the guidelines 
recommended for non-pregnant patients. Here we repot the first case of NSS performed 
simultaneously with CS for the treatment of pregnant woman with RCC. This approach can 
be considered feasible in women in the second and third trimesters of pregnancy. 
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